Our findings highlight several key genes, such as HLA-B, HLA-C, NRP1, and MUC2, and pathways, such as neurotransmitter regulation and lipid metabolism, which are implicated in the development and progression of MI and SMDs. Here, HLA-B is linked to spondylometaphyseal dysplasia, Sedaghatian type.